Methylxanthine drugs are chitinase inhibitors

investigation of inhibition and binding modes

Francesco V. Rao, Ole A. Andersen, Kalpit A. Vora, Julie A. DeMartino, Daan M. F. van Aalten

    Research output: Contribution to journalArticle

    75 Citations (Scopus)

    Abstract

    Family 18 chitinases play key roles in a range of pathogenic organisms and are overexpressed in the asthmatic lung. By screening a library of marketed drug molecules, we have identified methylxanthine derivatives as possible inhibitor leads. These derivatives, theophylline, caffeine, and pentoxifylline, are used therapeutically as antiinflammatory agents, with pleiotropic mechanisms of action. Here it is shown that they are also competitive inhibitors against a fungal family 18 chitinase, with pentoxifylline being the most potent (Ki of 37 µM). Crystallographic analysis of chitinase-inhibitor complexes revealed specific interactions with the active site, mimicking the reaction intermediate analog, allosamidin. Mutagenesis identified the key active site residues, conserved in mammalian chitinases, which contribute to inhibitor affinity. Enzyme assays also revealed that these methylxanthines are active against human chitinases.

    Original languageEnglish
    Pages (from-to)973-980
    Number of pages8
    JournalChemistry & Biology
    Volume12
    Issue number9
    DOIs
    Publication statusPublished - 1 Sep 2005

    Fingerprint

    Chitinases
    Pentoxifylline
    allosamidin
    Pharmaceutical Preparations
    Catalytic Domain
    Derivatives
    Reaction intermediates
    Mutagenesis
    Enzyme Assays
    Theophylline
    Caffeine
    Libraries
    Assays
    Screening
    Anti-Inflammatory Agents
    methylxanthine
    Lung
    Molecules
    Enzymes

    Cite this

    Rao, Francesco V. ; Andersen, Ole A. ; Vora, Kalpit A. ; DeMartino, Julie A. ; van Aalten, Daan M. F. / Methylxanthine drugs are chitinase inhibitors : investigation of inhibition and binding modes. In: Chemistry & Biology. 2005 ; Vol. 12, No. 9. pp. 973-980.
    @article{77ea91981b044728990517b0add1ada2,
    title = "Methylxanthine drugs are chitinase inhibitors: investigation of inhibition and binding modes",
    abstract = "Family 18 chitinases play key roles in a range of pathogenic organisms and are overexpressed in the asthmatic lung. By screening a library of marketed drug molecules, we have identified methylxanthine derivatives as possible inhibitor leads. These derivatives, theophylline, caffeine, and pentoxifylline, are used therapeutically as antiinflammatory agents, with pleiotropic mechanisms of action. Here it is shown that they are also competitive inhibitors against a fungal family 18 chitinase, with pentoxifylline being the most potent (Ki of 37 µM). Crystallographic analysis of chitinase-inhibitor complexes revealed specific interactions with the active site, mimicking the reaction intermediate analog, allosamidin. Mutagenesis identified the key active site residues, conserved in mammalian chitinases, which contribute to inhibitor affinity. Enzyme assays also revealed that these methylxanthines are active against human chitinases.",
    author = "Rao, {Francesco V.} and Andersen, {Ole A.} and Vora, {Kalpit A.} and DeMartino, {Julie A.} and {van Aalten}, {Daan M. F.}",
    note = "MEDLINE{\circledR} is the source for the MeSH terms of this document.",
    year = "2005",
    month = "9",
    day = "1",
    doi = "10.1016/j.chembiol.2005.07.009",
    language = "English",
    volume = "12",
    pages = "973--980",
    journal = "Chemistry & Biology",
    issn = "1074-5521",
    publisher = "Elsevier",
    number = "9",

    }

    Methylxanthine drugs are chitinase inhibitors : investigation of inhibition and binding modes. / Rao, Francesco V.; Andersen, Ole A.; Vora, Kalpit A.; DeMartino, Julie A.; van Aalten, Daan M. F.

    In: Chemistry & Biology, Vol. 12, No. 9, 01.09.2005, p. 973-980.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Methylxanthine drugs are chitinase inhibitors

    T2 - investigation of inhibition and binding modes

    AU - Rao, Francesco V.

    AU - Andersen, Ole A.

    AU - Vora, Kalpit A.

    AU - DeMartino, Julie A.

    AU - van Aalten, Daan M. F.

    N1 - MEDLINE® is the source for the MeSH terms of this document.

    PY - 2005/9/1

    Y1 - 2005/9/1

    N2 - Family 18 chitinases play key roles in a range of pathogenic organisms and are overexpressed in the asthmatic lung. By screening a library of marketed drug molecules, we have identified methylxanthine derivatives as possible inhibitor leads. These derivatives, theophylline, caffeine, and pentoxifylline, are used therapeutically as antiinflammatory agents, with pleiotropic mechanisms of action. Here it is shown that they are also competitive inhibitors against a fungal family 18 chitinase, with pentoxifylline being the most potent (Ki of 37 µM). Crystallographic analysis of chitinase-inhibitor complexes revealed specific interactions with the active site, mimicking the reaction intermediate analog, allosamidin. Mutagenesis identified the key active site residues, conserved in mammalian chitinases, which contribute to inhibitor affinity. Enzyme assays also revealed that these methylxanthines are active against human chitinases.

    AB - Family 18 chitinases play key roles in a range of pathogenic organisms and are overexpressed in the asthmatic lung. By screening a library of marketed drug molecules, we have identified methylxanthine derivatives as possible inhibitor leads. These derivatives, theophylline, caffeine, and pentoxifylline, are used therapeutically as antiinflammatory agents, with pleiotropic mechanisms of action. Here it is shown that they are also competitive inhibitors against a fungal family 18 chitinase, with pentoxifylline being the most potent (Ki of 37 µM). Crystallographic analysis of chitinase-inhibitor complexes revealed specific interactions with the active site, mimicking the reaction intermediate analog, allosamidin. Mutagenesis identified the key active site residues, conserved in mammalian chitinases, which contribute to inhibitor affinity. Enzyme assays also revealed that these methylxanthines are active against human chitinases.

    UR - http://www.scopus.com/inward/record.url?scp=25144468884&partnerID=8YFLogxK

    U2 - 10.1016/j.chembiol.2005.07.009

    DO - 10.1016/j.chembiol.2005.07.009

    M3 - Article

    VL - 12

    SP - 973

    EP - 980

    JO - Chemistry & Biology

    JF - Chemistry & Biology

    SN - 1074-5521

    IS - 9

    ER -